Catherine C. Lee - 05 May 2021 Form 4 Insider Report for Metacrine, Inc.

Reporting relationship: EVP, Gen. Counsel & Secretary
Issuer ticker: N/A
Reported as of: 05 May 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 May 2021, 18:36:34 UTC
Next SEC filing: 04 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Catherine C. Lee

Key filing fact

Catherine C. Lee filed Form 4 for Metacrine, Inc. on 07 May 2021.

Key facts

This page summarizes Catherine C. Lee's Form 4 filing for Metacrine, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 May 2021, 18:36.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MTCR transaction

Common Stock

Award

Transaction value
Shares: +3,846
Change %
Price
Shares after: 3,846
Date: 05 May 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Although not required, the Reporting Person has elected to report 3,846 shares of Common Stock that were acquired by the Reporting Person on 5/5/2021 pursuant to the Issuer's Employee Stock Purchase Plan